Ro Offers Eli Lilly's Foundayo, the Newest GLP-1 Innovation Foundayo gives patients a new once daily pill option and expands Ros comprehensive weight loss formulary April 9, 2026 Ro, the leading direct-to-patient healthcare company, today announced eligible patients can now access Foundayo (orforglipron) Eli Lilly Companys newest oral GLP-1 innovation on the Ro platform, adding to Ros already comprehensive formulary of FDA-approved GLP-1s
This synergistic formula targets metabolic pathways from multiple anglesfueling your body with clean protein while supporting hormonal balance, glucose control, recovery, and fat utilization
The same underlying story of whats possible when youre on Ro
This can be achieved through various methods such as sonication, freeze-thaw cycles, enzymatic digestion (e.g., lysozyme treatment), or mechanical disruption (e.g., French press)
Testosterone for Men Over 50 FAQs Will taking testosterone boosters or medical TRT cause me to lose my hair